Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,322 | -17,626 | -11,027 | -4,403 | -21,025 |
| Depreciation Amortization | 78 | 58 | 38 | 18 | 54 |
| Other Working Capital | 1,688 | 342 | -154 | 245 | -821 |
| Other Operating Activity | 1,767 | 678 | 165 | -617 | 3,249 |
| Operating Cash Flow | $-20,789 | $-16,548 | $-10,978 | $-4,757 | $-18,544 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -60 | -43 | -42 | -28 | -48 |
| Other Investing Activity | -50 | -50 | -50 | -50 | 0 |
| Investing Cash Flow | $-110 | $-93 | $-91 | $-77 | $-48 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -266 | -266 | -176 | -88 | -284 |
| Common Stock Issued | 16,041 | 6,791 | 6,058 | 1,485 | 37,654 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 158 |
| Financing Cash Flow | $15,775 | $6,525 | $5,882 | $1,398 | $37,528 |
| Beginning Cash Position | 25,678 | 25,643 | 25,643 | 25,643 | 6,707 |
| End Cash Position | 20,554 | 15,527 | 20,455 | 22,207 | 25,643 |
| Net Cash Flow | $-5,124 | $-10,116 | $-5,188 | $-3,436 | $18,937 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,789 | -16,548 | -10,978 | -4,757 | -18,544 |
| Capital Expenditure | -60 | -43 | -42 | -28 | -48 |
| Free Cash Flow | -20,849 | -16,591 | -11,020 | -4,784 | -18,592 |